Amgen Inc.
Anti-PD-1 Antibodies and Methods of Treatment
Last updated:
Abstract:
Provided herein are PD-1 antigen-binding proteins and related nucleic acids, vectors, host cells, kits and pharmaceutical compositions. Methods of making PD-1 antigen-binding proteins and methods of treating a subject are further provided.
Status:
Application
Type:
Utility
Filling date:
11 Jan 2019
Issue date:
5 Sep 2019